Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2008: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Research Abstract |
The aim of the present study is to design and evaluate novel supramolecular-based drug delivery system having sustained release, long-circulating and tumor-selective properties for siRNA and shRNA, which are known to be an ultimate molecularly-targeted drug. Eventually, these results suggest that PEG-Fol-α-CDE/γ-CyD supramolecular complexes have the potential for novel siRNA delivery system having sustained release, long-circulating and tumor-selective properties.
|